Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK MHRA Response To Brexit Questions Still Leaves Gaps And Uncertainty For Medtech

Executive Summary

As UK Prime Minister Theresa May tries to get her cabinet to accept the draft Brexit agreement between the UK and EU, Medtech Insight looks at the potential confusion for medtech should she fail.

You may also be interested in...



Questions Abound: UK MHRA Brexit Proposal For Medtech Leaves Much Unsaid, Much To Fear

Questions outnumber answers for medtech following the UK's recently issued "technical notices" on the implications if the UK does not reach a Brexit agreement with the EU before March 2019. Below we list the critical outstanding questions based on a Medtech Insight analysis and discussion with several top experts in the field. These questions have also been put directly to the UK's MHRA and the European Commission.

MedTech Europe CEO Shakes Up Industry On Brexit In Mission To Help It

"Expect and prepare for the worst," MedTech Europe's Serge Bernasconi recently said in Brussels. "Don't expect concessions." The words spoken by the association leader on Brexit leave delegates uncomfortable and revisiting what to do.

Commission Spells Out Non-Recognition Of UK Organizations In Future EU

While the details of UK's Brexit deal are not finalized, those paralyzed in disbelief at the enormity of the fallout will have to act. The European Commission spells out the upheaval necessary for medtech to realign into the EU-27.

Topics

UsernamePublicRestriction

Register

LL1131980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel